Answer
Women of childbearing potential should use effective contraception throughout guselkumab treatment and for at least 12 weeks after treatment.
Sources for this answer
- Tremfya 100 mg OnePress solution for injection in pre-filled penJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 16Document updated
Sources checked